Skip to main navigation Skip to search Skip to main content

Evaluation of acute myeloid leukemia induction regimens in elderly patients with unfavorable risk cytogenetics that are candidates for intensive remission therapy

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Mar 1 2020

Disciplines

  • Medicine and Health Sciences
  • Pharmacy and Pharmaceutical Sciences

Cite this